Global and Japan RNA Interference (RNAi) Drug Delivery Market Insights, Forecast to 2026

Global and Japan RNA Interference (RNAi) Drug Delivery Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 RNA Interference (RNAi) Drug Delivery Product Introduction
1.2 Market Segments
1.3 Key RNA Interference (RNAi) Drug Delivery Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global RNA Interference (RNAi) Drug Delivery Market Size Growth Rate by Type
1.4.2 Nanoparticle Drug Delivery Technology
1.4.3 Pulmonary Drug Delivery Technology
1.4.4 Nucleic Acid Drug Delivery Technology
1.4.5 Aptamer Drug Delivery Technology
1.5 Market by Application
1.5.1 Global RNA Interference (RNAi) Drug Delivery Market Size Growth Rate by Application
1.5.2 Infectious Diseases
1.5.3 Cardiology
1.5.4 Oncology
1.5.5 Neurology
1.5.6 Ophthalmology
1.5.7 Metabolic Disorders
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global RNA Interference (RNAi) Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global RNA Interference (RNAi) Drug Delivery Revenue 2015-2026
2.1.2 Global RNA Interference (RNAi) Drug Delivery Sales 2015-2026
2.2 Global RNA Interference (RNAi) Drug Delivery, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 RNA Interference (RNAi) Drug Delivery Historical Market Size by Region (2015-2020)
2.3.1 Global RNA Interference (RNAi) Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global RNA Interference (RNAi) Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 RNA Interference (RNAi) Drug Delivery Market Estimates and Projections by Region (2021-2026)
2.4.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Region (2021-2026)
2.4.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Region (2021-2026)
3 Global RNA Interference (RNAi) Drug Delivery Competitor Landscape by Players
3.1 Global Top RNA Interference (RNAi) Drug Delivery Sales by Manufacturers
3.1.1 Global RNA Interference (RNAi) Drug Delivery Sales by Manufacturers (2015-2020)
3.1.2 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Manufacturers (2015-2020)
3.2 Global RNA Interference (RNAi) Drug Delivery Manufacturers by Revenue
3.2.1 Global RNA Interference (RNAi) Drug Delivery Revenue by Manufacturers (2015-2020)
3.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Share by Manufacturers (2015-2020)
3.2.3 Global RNA Interference (RNAi) Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by RNA Interference (RNAi) Drug Delivery Revenue in 2019
3.2.5 Global RNA Interference (RNAi) Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global RNA Interference (RNAi) Drug Delivery Price by Manufacturers
3.4 Global RNA Interference (RNAi) Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 RNA Interference (RNAi) Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into RNA Interference (RNAi) Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global RNA Interference (RNAi) Drug Delivery Market Size by Type (2015-2020)
4.1.1 Global RNA Interference (RNAi) Drug Delivery Sales by Type (2015-2020)
4.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue by Type (2015-2020)
4.1.3 RNA Interference (RNAi) Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
4.2 Global RNA Interference (RNAi) Drug Delivery Market Size Forecast by Type (2021-2026)
4.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 RNA Interference (RNAi) Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global RNA Interference (RNAi) Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global RNA Interference (RNAi) Drug Delivery Market Size by Application (2015-2020)
5.1.1 Global RNA Interference (RNAi) Drug Delivery Sales by Application (2015-2020)
5.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue by Application (2015-2020)
5.1.3 RNA Interference (RNAi) Drug Delivery Price by Application (2015-2020)
5.2 RNA Interference (RNAi) Drug Delivery Market Size Forecast by Application (2021-2026)
5.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global RNA Interference (RNAi) Drug Delivery Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan RNA Interference (RNAi) Drug Delivery Market Size YoY Growth 2015-2026
6.1.1 Japan RNA Interference (RNAi) Drug Delivery Sales YoY Growth 2015-2026
6.1.2 Japan RNA Interference (RNAi) Drug Delivery Revenue YoY Growth 2015-2026
6.1.3 Japan RNA Interference (RNAi) Drug Delivery Market Share in Global Market 2015-2026
6.2 Japan RNA Interference (RNAi) Drug Delivery Market Size by Players (International and Local Players)
6.2.1 Japan Top RNA Interference (RNAi) Drug Delivery Players by Sales (2015-2020)
6.2.2 Japan Top RNA Interference (RNAi) Drug Delivery Players by Revenue (2015-2020)
6.3 Japan RNA Interference (RNAi) Drug Delivery Historic Market Review by Type (2015-2020)
6.3.1 Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
6.3.2 Japan RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type (2015-2020)
6.3.3 Japan RNA Interference (RNAi) Drug Delivery Price by Type (2015-2020)
6.4 Japan RNA Interference (RNAi) Drug Delivery Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan RNA Interference (RNAi) Drug Delivery Sales Forecast by Type (2021-2026)
6.4.2 Japan RNA Interference (RNAi) Drug Delivery Revenue Forecast by Type (2021-2026)
6.4.3 Japan RNA Interference (RNAi) Drug Delivery Price Forecast by Type (2021-2026)
6.5 Japan RNA Interference (RNAi) Drug Delivery Historic Market Review by Application (2015-2020)
6.5.1 Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
6.5.2 Japan RNA Interference (RNAi) Drug Delivery Revenue Market Share by Application (2015-2020)
6.5.3 Japan RNA Interference (RNAi) Drug Delivery Price by Application (2015-2020)
6.6 Japan RNA Interference (RNAi) Drug Delivery Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan RNA Interference (RNAi) Drug Delivery Sales Forecast by Application (2021-2026)
6.6.2 Japan RNA Interference (RNAi) Drug Delivery Revenue Forecast by Application (2021-2026)
6.6.3 Japan RNA Interference (RNAi) Drug Delivery Price Forecast by Application (2021-2026)
7 North America
7.1 North America RNA Interference (RNAi) Drug Delivery Market Size YoY Growth 2015-2026
7.2 North America RNA Interference (RNAi) Drug Delivery Market Facts & Figures by Country
7.2.1 North America RNA Interference (RNAi) Drug Delivery Sales by Country (2015-2020)
7.2.2 North America RNA Interference (RNAi) Drug Delivery Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe RNA Interference (RNAi) Drug Delivery Market Size YoY Growth 2015-2026
8.2 Europe RNA Interference (RNAi) Drug Delivery Market Facts & Figures by Country
8.2.1 Europe RNA Interference (RNAi) Drug Delivery Sales by Country
8.2.2 Europe RNA Interference (RNAi) Drug Delivery Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific RNA Interference (RNAi) Drug Delivery Market Size YoY Growth 2015-2026
9.2 Asia Pacific RNA Interference (RNAi) Drug Delivery Market Facts & Figures by Country
9.2.1 Asia Pacific RNA Interference (RNAi) Drug Delivery Sales by Region (2015-2020)
9.2.2 Asia Pacific RNA Interference (RNAi) Drug Delivery Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America RNA Interference (RNAi) Drug Delivery Market Size YoY Growth 2015-2026
10.2 Latin America RNA Interference (RNAi) Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America RNA Interference (RNAi) Drug Delivery Sales by Country
10.2.2 Latin America RNA Interference (RNAi) Drug Delivery Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa RNA Interference (RNAi) Drug Delivery Market Size YoY Growth 2015-2026
11.2 Middle East and Africa RNA Interference (RNAi) Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales by Country
11.2.2 Middle East and Africa RNA Interference (RNAi) Drug Delivery Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Metabolic disorders
12.1.1 Metabolic disorders Corporation Information
12.1.2 Metabolic disorders Description and Business Overview
12.1.3 Metabolic disorders Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Metabolic disorders RNA Interference (RNAi) Drug Delivery Products Offered
12.1.5 Metabolic disorders Recent Development
12.2 Alnylam Pharmaceuticals Inc
12.2.1 Alnylam Pharmaceuticals Inc Corporation Information
12.2.2 Alnylam Pharmaceuticals Inc Description and Business Overview
12.2.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.2.5 Alnylam Pharmaceuticals Inc Recent Development
12.3 Merck & Co. Inc
12.3.1 Merck & Co. Inc Corporation Information
12.3.2 Merck & Co. Inc Description and Business Overview
12.3.3 Merck & Co. Inc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.3.5 Merck & Co. Inc Recent Development
12.4 Access Pharmaceuticals Inc
12.4.1 Access Pharmaceuticals Inc Corporation Information
12.4.2 Access Pharmaceuticals Inc Description and Business Overview
12.4.3 Access Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.4.5 Access Pharmaceuticals Inc Recent Development
12.5 Dicerna Pharmaceuticals Inc
12.5.1 Dicerna Pharmaceuticals Inc Corporation Information
12.5.2 Dicerna Pharmaceuticals Inc Description and Business Overview
12.5.3 Dicerna Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.5.5 Dicerna Pharmaceuticals Inc Recent Development
12.6 Calondo Pharmaceuticals Inc
12.6.1 Calondo Pharmaceuticals Inc Corporation Information
12.6.2 Calondo Pharmaceuticals Inc Description and Business Overview
12.6.3 Calondo Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.6.5 Calondo Pharmaceuticals Inc Recent Development
12.7 Marina Biotech Inc
12.7.1 Marina Biotech Inc Corporation Information
12.7.2 Marina Biotech Inc Description and Business Overview
12.7.3 Marina Biotech Inc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.7.5 Marina Biotech Inc Recent Development
12.8 RXi Pharmaceuticals Corp
12.8.1 RXi Pharmaceuticals Corp Corporation Information
12.8.2 RXi Pharmaceuticals Corp Description and Business Overview
12.8.3 RXi Pharmaceuticals Corp Sales, Revenue and Gross Margin (2015-2020)
12.8.4 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Products Offered
12.8.5 RXi Pharmaceuticals Corp Recent Development
12.9 Quark Pharmaceuticals Inc
12.9.1 Quark Pharmaceuticals Inc Corporation Information
12.9.2 Quark Pharmaceuticals Inc Description and Business Overview
12.9.3 Quark Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.9.5 Quark Pharmaceuticals Inc Recent Development
12.10 Silence Therapeutics plc
12.10.1 Silence Therapeutics plc Corporation Information
12.10.2 Silence Therapeutics plc Description and Business Overview
12.10.3 Silence Therapeutics plc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Products Offered
12.10.5 Silence Therapeutics plc Recent Development
12.11 Metabolic disorders
12.11.1 Metabolic disorders Corporation Information
12.11.2 Metabolic disorders Description and Business Overview
12.11.3 Metabolic disorders Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Metabolic disorders RNA Interference (RNAi) Drug Delivery Products Offered
12.11.5 Metabolic disorders Recent Development
12.12 PhaseRx Inc
12.12.1 PhaseRx Inc Corporation Information
12.12.2 PhaseRx Inc Description and Business Overview
12.12.3 PhaseRx Inc Sales, Revenue and Gross Margin (2015-2020)
12.12.4 PhaseRx Inc Products Offered
12.12.5 PhaseRx Inc Recent Development
12.13 Sirnaomics Inc
12.13.1 Sirnaomics Inc Corporation Information
12.13.2 Sirnaomics Inc Description and Business Overview
12.13.3 Sirnaomics Inc Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sirnaomics Inc Products Offered
12.13.5 Sirnaomics Inc Recent Development
12.14 Traversa Therapeutics Inc
12.14.1 Traversa Therapeutics Inc Corporation Information
12.14.2 Traversa Therapeutics Inc Description and Business Overview
12.14.3 Traversa Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Traversa Therapeutics Inc Products Offered
12.14.5 Traversa Therapeutics Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key RNA Interference (RNAi) Drug Delivery Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNA Interference (RNAi) Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. RNA Interference (RNAi) Drug Delivery Market Segments
Table 2. Ranking of Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global RNA Interference (RNAi) Drug Delivery Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Nanoparticle Drug Delivery Technology
Table 5. Major Manufacturers of Pulmonary Drug Delivery Technology
Table 6. Major Manufacturers of Nucleic Acid Drug Delivery Technology
Table 7. Major Manufacturers of Aptamer Drug Delivery Technology
Table 8. Global RNA Interference (RNAi) Drug Delivery Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global RNA Interference (RNAi) Drug Delivery Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global RNA Interference (RNAi) Drug Delivery Sales by Regions 2015-2020 (K Units)
Table 11. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Regions (2015-2020)
Table 12. Global RNA Interference (RNAi) Drug Delivery Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Region (2021-2026) (K Units)
Table 14. Global RNA Interference (RNAi) Drug Delivery Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global RNA Interference (RNAi) Drug Delivery Sales Share by Manufacturers (2015-2020)
Table 16. Global RNA Interference (RNAi) Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global RNA Interference (RNAi) Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Interference (RNAi) Drug Delivery as of 2019)
Table 18. RNA Interference (RNAi) Drug Delivery Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. RNA Interference (RNAi) Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers RNA Interference (RNAi) Drug Delivery Price (2015-2020) (USD/Unit)
Table 21. RNA Interference (RNAi) Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
Table 23. Date of International Manufacturers Enter into RNA Interference (RNAi) Drug Delivery Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Interference (RNAi) Drug Delivery Sales by Type (2015-2020) (K Units)
Table 26. Global RNA Interference (RNAi) Drug Delivery Sales Share by Type (2015-2020)
Table 27. Global RNA Interference (RNAi) Drug Delivery Revenue by Type (2015-2020) (US$ Million)
Table 28. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2015-2020)
Table 29. RNA Interference (RNAi) Drug Delivery Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global RNA Interference (RNAi) Drug Delivery Sales Share by Type (2021-2026)
Table 31. Global RNA Interference (RNAi) Drug Delivery Sales by Application (2015-2020) (K Units)
Table 32. Global RNA Interference (RNAi) Drug Delivery Sales Share by Application (2015-2020)
Table 33. Global RNA Interference (RNAi) Drug Delivery Sales Share by Application (2021-2026)
Table 34. Global RNA Interference (RNAi) Drug Delivery Sales Market Share Forecast by Application (2021-2026)
Table 35. Global RNA Interference (RNAi) Drug Delivery Revenue by Application (2015-2020) (US$ Million)
Table 36. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Application (2021-2026)
Table 37. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) of Key Companies (2015-2020)
Table 38. Japan RNA Interference (RNAi) Drug Delivery Sales Share by Company (2015-2020)
Table 39. Japan RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) by Company (2015-2020)
Table 40. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 41. Japan RNA Interference (RNAi) Drug Delivery Sales Share by Type (2015-2020)
Table 42. Japan RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Japan RNA Interference (RNAi) Drug Delivery Price (K Units) by Type (2015-2020)
Table 44. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2021-2026)
Table 45. Japan RNA Interference (RNAi) Drug Delivery Sales Share by Type (2021-2026)
Table 46. Japan RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Japan RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2021-2026)
Table 48. Japan RNA Interference (RNAi) Drug Delivery Price (K Units) by Type (2021-2026)
Table 49. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 50. Japan RNA Interference (RNAi) Drug Delivery Sales Share by Application (2015-2020)
Table 51. Japan RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2021-2026)
Table 53. Japan RNA Interference (RNAi) Drug Delivery Sales Share by Application (2021-2026)
Table 54. Japan RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Japan RNA Interference (RNAi) Drug Delivery Revenue Share by Application (2021-2026)
Table 56. North America RNA Interference (RNAi) Drug Delivery Sales by Country (2015-2020) (K Units)
Table 57. North America RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2015-2020)
Table 58. North America RNA Interference (RNAi) Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 59. North America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2015-2020)
Table 60. Europe RNA Interference (RNAi) Drug Delivery Sales by Country (2015-2020) (K Units)
Table 61. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2015-2020)
Table 62. Europe RNA Interference (RNAi) Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific RNA Interference (RNAi) Drug Delivery Sales by Region (2015-2020) (K Units)
Table 65. Asia Pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific RNA Interference (RNAi) Drug Delivery Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2015-2020)
Table 68. Latin America RNA Interference (RNAi) Drug Delivery Sales by Country (2015-2020) (K Units)
Table 69. Latin America RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa RNA Interference (RNAi) Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales by Country (2015-2020) (K Units)
Table 73. Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa RNA Interference (RNAi) Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2015-2020)
Table 76. Metabolic disorders Corporation Information
Table 77. Metabolic disorders Description and Business Overview
Table 78. Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Metabolic disorders RNA Interference (RNAi) Drug Delivery Product
Table 80. Metabolic disorders Recent Development
Table 81. Alnylam Pharmaceuticals Inc Corporation Information
Table 82. Alnylam Pharmaceuticals Inc Description and Business Overview
Table 83. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Alnylam Pharmaceuticals Inc Product
Table 85. Alnylam Pharmaceuticals Inc Recent Development
Table 86. Merck & Co. Inc Corporation Information
Table 87. Merck & Co. Inc Description and Business Overview
Table 88. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Merck & Co. Inc Product
Table 90. Merck & Co. Inc Recent Development
Table 91. Access Pharmaceuticals Inc Corporation Information
Table 92. Access Pharmaceuticals Inc Description and Business Overview
Table 93. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Access Pharmaceuticals Inc Product
Table 95. Access Pharmaceuticals Inc Recent Development
Table 96. Dicerna Pharmaceuticals Inc Corporation Information
Table 97. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 98. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Dicerna Pharmaceuticals Inc Product
Table 100. Dicerna Pharmaceuticals Inc Recent Development
Table 101. Calondo Pharmaceuticals Inc Corporation Information
Table 102. Calondo Pharmaceuticals Inc Description and Business Overview
Table 103. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Calondo Pharmaceuticals Inc Product
Table 105. Calondo Pharmaceuticals Inc Recent Development
Table 106. Marina Biotech Inc Corporation Information
Table 107. Marina Biotech Inc Description and Business Overview
Table 108. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Marina Biotech Inc Product
Table 110. Marina Biotech Inc Recent Development
Table 111. RXi Pharmaceuticals Corp Corporation Information
Table 112. RXi Pharmaceuticals Corp Description and Business Overview
Table 113. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. RXi Pharmaceuticals Corp Product
Table 115. RXi Pharmaceuticals Corp Recent Development
Table 116. Quark Pharmaceuticals Inc Corporation Information
Table 117. Quark Pharmaceuticals Inc Description and Business Overview
Table 118. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Quark Pharmaceuticals Inc Product
Table 120. Quark Pharmaceuticals Inc Recent Development
Table 121. Silence Therapeutics plc Corporation Information
Table 122. Silence Therapeutics plc Description and Business Overview
Table 123. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Silence Therapeutics plc Product
Table 125. Silence Therapeutics plc Recent Development
Table 126. Tacere Therapeutics Inc Corporation Information
Table 127. Tacere Therapeutics Inc Description and Business Overview
Table 128. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Tacere Therapeutics Inc Product
Table 130. Tacere Therapeutics Inc Recent Development
Table 131. PhaseRx Inc Corporation Information
Table 132. PhaseRx Inc Description and Business Overview
Table 133. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. PhaseRx Inc Product
Table 135. PhaseRx Inc Recent Development
Table 136. Sirnaomics Inc Corporation Information
Table 137. Sirnaomics Inc Description and Business Overview
Table 138. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Sirnaomics Inc Product
Table 140. Sirnaomics Inc Recent Development
Table 141. Traversa Therapeutics Inc Corporation Information
Table 142. Traversa Therapeutics Inc Description and Business Overview
Table 143. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Traversa Therapeutics Inc Product
Table 145. Traversa Therapeutics Inc Recent Development
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key RNA Interference (RNAi) Drug Delivery Players
Table 150. RNA Interference (RNAi) Drug Delivery Customers List
Table 151. RNA Interference (RNAi) Drug Delivery Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Interference (RNAi) Drug Delivery Product Picture
Figure 2. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Nanoparticle Drug Delivery Technology Product Picture
Figure 4. Pulmonary Drug Delivery Technology Product Picture
Figure 5. Nucleic Acid Drug Delivery Technology Product Picture
Figure 6. Aptamer Drug Delivery Technology Product Picture
Figure 7. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2020 & 2026
Figure 8. Infectious Diseases
Figure 9. Cardiology
Figure 10. Oncology
Figure 11. Neurology
Figure 12. Ophthalmology
Figure 13. Metabolic Disorders
Figure 14. RNA Interference (RNAi) Drug Delivery Report Years Considered
Figure 15. Global RNA Interference (RNAi) Drug Delivery Market Size 2015-2026 (US$ Million)
Figure 16. Global RNA Interference (RNAi) Drug Delivery Sales 2015-2026 (K Units)
Figure 17. Global RNA Interference (RNAi) Drug Delivery Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Region (2015-2020)
Figure 19. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Region in 2019
Figure 20. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 21. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region in 2019
Figure 22. Global RNA Interference (RNAi) Drug Delivery Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by RNA Interference (RNAi) Drug Delivery Revenue in 2019
Figure 24. RNA Interference (RNAi) Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Figure 26. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 27. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type (2015-2020)
Figure 28. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type in 2019
Figure 29. Global RNA Interference (RNAi) Drug Delivery Market Share by Price Range (2015-2020)
Figure 30. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
Figure 31. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2019
Figure 32. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Application (2015-2020)
Figure 33. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Application in 2019
Figure 34. Japan RNA Interference (RNAi) Drug Delivery Sales Growth Rate 2015-2026 (K Units)
Figure 35. Japan RNA Interference (RNAi) Drug Delivery Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. Japan RNA Interference (RNAi) Drug Delivery Market Share in Global Market 2015-2026
Figure 37. Japan 5 and 10 Largest RNA Interference (RNAi) Drug Delivery Players Market Share by Revenue in RNA Interference (RNAi) Drug Delivery in 2019
Figure 38. Japan RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2015-2020)
Figure 39. Japan RNA Interference (RNAi) Drug Delivery Revenue Growth Rate by Type in 2015 & 2019
Figure 40. Japan RNA Interference (RNAi) Drug Delivery Revenue Share by Application (2015-2020)
Figure 41. Japan RNA Interference (RNAi) Drug Delivery Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America RNA Interference (RNAi) Drug Delivery Sales Growth Rate 2015-2020 (K Units)
Figure 43. North America RNA Interference (RNAi) Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America RNA Interference (RNAi) Drug Delivery Sales Market Share by Country in 2019
Figure 45. North America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Count

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs